Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03268057
Title VX15/2503 in Combination With Avelumab in Advanced Non-small Cell Lung Cancer
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Vaccinex Inc.

lung non-small cell carcinoma


Avelumab + Pepinemab

Age Groups: senior | adult
Covered Countries USA

Additional content available in CKB BOOST